Epibiotech Co., Ltd. (XKON:446440)
14,450
+500 (3.58%)
At close: Mar 6, 2026
21.53% (1Y)
| Market Cap | 33.33B |
| Revenue (ttm) | 449.62M |
| Net Income (ttm) | -5.06B |
| Shares Out | 2.31M |
| EPS (ttm) | -2,966.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2 |
| Average Volume | 111 |
| Open | 14,440 |
| Previous Close | 13,950 |
| Day's Range | 14,440 - 14,450 |
| 52-Week Range | 9,600 - 19,000 |
| Beta | 0.98 |
| RSI | 50.12 |
| Earnings Date | n/a |